288 related articles for article (PubMed ID: 15476859)
21. [Advances in Research of Antitumor Mechanisms of Isothiocyanates].
Wang H; Xu K
Zhongguo Fei Ai Za Zhi; 2017 Mar; 20(3):213-218. PubMed ID: 28302225
[TBL] [Abstract][Full Text] [Related]
22. Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis.
Mi L; Xiao Z; Hood BL; Dakshanamurthy S; Wang X; Govind S; Conrads TP; Veenstra TD; Chung FL
J Biol Chem; 2008 Aug; 283(32):22136-46. PubMed ID: 18524779
[TBL] [Abstract][Full Text] [Related]
23. Isothiocyanates: a class of bioactive metabolites with chemopreventive potential.
Kumar G; Tuli HS; Mittal S; Shandilya JK; Tiwari A; Sandhu SS
Tumour Biol; 2015 Jun; 36(6):4005-16. PubMed ID: 25835976
[TBL] [Abstract][Full Text] [Related]
24. Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress.
Zhang Y; Li J; Tang L
Free Radic Biol Med; 2005 Jan; 38(1):70-7. PubMed ID: 15589373
[TBL] [Abstract][Full Text] [Related]
25. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables.
Shapiro TA; Fahey JW; Wade KL; Stephenson KK; Talalay P
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1091-100. PubMed ID: 9865427
[TBL] [Abstract][Full Text] [Related]
26. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk.
Zhao H; Lin J; Grossman HB; Hernandez LM; Dinney CP; Wu X
Int J Cancer; 2007 May; 120(10):2208-13. PubMed ID: 17290402
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic impact of dietary isothiocyanates in cancer chemoprevention.
Gerhauser C
Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):405-10. PubMed ID: 23657153
[TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic effects of dietary isothiocyanates: mechanisms of action and implications for human health.
Cavell BE; Syed Alwi SS; Donlevy A; Packham G
Biochem Pharmacol; 2011 Feb; 81(3):327-36. PubMed ID: 20955689
[TBL] [Abstract][Full Text] [Related]
29. Sulforaphane as a promising molecule for fighting cancer.
Fimognari C; Hrelia P
Mutat Res; 2007; 635(2-3):90-104. PubMed ID: 17134937
[TBL] [Abstract][Full Text] [Related]
30. CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells.
Sakao K; Vyas AR; Chinni SR; Amjad AI; Parikh R; Singh SV
Cancer Prev Res (Phila); 2015 May; 8(5):365-74. PubMed ID: 25712054
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates.
Zhang Y
Carcinogenesis; 2001 Mar; 22(3):425-31. PubMed ID: 11238182
[TBL] [Abstract][Full Text] [Related]
32. Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes.
Conaway CC; Krzeminski J; Amin S; Chung FL
Chem Res Toxicol; 2001 Sep; 14(9):1170-6. PubMed ID: 11559030
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis.
Yang YM; Conaway CC; Chiao JW; Wang CX; Amin S; Whysner J; Dai W; Reinhardt J; Chung FL
Cancer Res; 2002 Jan; 62(1):2-7. PubMed ID: 11782348
[TBL] [Abstract][Full Text] [Related]
34. Micronucleus formation and induction of apoptosis by different isothiocyanates and a mixture of isothiocyanates in human lymphocyte cultures.
Fimognari C; Berti F; Iori R; Cantelli-Forti G; Hrelia P
Mutat Res; 2005 Apr; 582(1-2):1-10. PubMed ID: 15781204
[TBL] [Abstract][Full Text] [Related]
35. [A case-control study on the association between urinary levels of isothiocyanates and the risk of pancreatic cancer].
Wang J; Han L; Zhang W; Wang J; Ni Q; Shen M; Gao Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Mar; 48(3):172-6. PubMed ID: 24844828
[TBL] [Abstract][Full Text] [Related]
36. The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells.
Tang L; Li G; Song L; Zhang Y
Anticancer Drugs; 2006 Mar; 17(3):297-305. PubMed ID: 16520658
[TBL] [Abstract][Full Text] [Related]
37. Nanodelivery of natural isothiocyanates as a cancer therapeutic.
Wang Q; Bao Y
Free Radic Biol Med; 2021 May; 167():125-140. PubMed ID: 33711418
[TBL] [Abstract][Full Text] [Related]
38. Isothiocyanates: mechanism of cancer chemopreventive action.
Thornalley PJ
Anticancer Drugs; 2002 Apr; 13(4):331-8. PubMed ID: 11984078
[TBL] [Abstract][Full Text] [Related]
39. The 1,2-benzenedithiole-based cyclocondensation assay: a valuable tool for the measurement of chemopreventive isothiocyanates.
Zhang Y
Crit Rev Food Sci Nutr; 2012; 52(6):525-32. PubMed ID: 22452732
[TBL] [Abstract][Full Text] [Related]
40. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells.
Zhang Y
Carcinogenesis; 2000 Jun; 21(6):1175-82. PubMed ID: 10837007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
